Menu
GWAS Study

Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.

Law PJ, Berndt SI, Speedy HE et al.

28165464 PubMed ID
GWAS Study Type
23798 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LP
Law PJ
BS
Berndt SI
SH
Speedy HE
CN
Camp NJ
SG
Sava GP
SC
Skibola CF
HA
Holroyd A
JV
Joseph V
SN
Sunter NJ
NA
Nieters A
BS
Bea S
MA
Monnereau A
MD
Martin-Garcia D
GL
Goldin LR
CG
Clot G
TL
Teras LR
QI
Quintela I
BB
Birmann BM
JS
Jayne S
CW
Cozen W
MA
Majid A
SK
Smedby KE
LQ
Lan Q
DC
Dearden C
BA
Brooks-Wilson AR
HA
Hall AG
PM
Purdue MP
MT
Mainou-Fowler T
VC
Vajdic CM
JG
Jackson GH
CP
Cocco P
MH
Marr H
ZY
Zhang Y
ZT
Zheng T
GG
Giles GG
LC
Lawrence C
CT
Call TG
LM
Liebow M
MM
Melbye M
GB
Glimelius B
ML
Mansouri L
GM
Glenn M
CK
Curtin K
DW
Diver WR
LB
Link BK
CL
Conde L
BP
Bracci PM
HE
Holly EA
JR
Jackson RD
TL
Tinker LF
BY
Benavente Y
BP
Boffetta P
BP
Brennan P
MM
Maynadie M
MJ
McKay J
AD
Albanes D
WS
Weinstein S
WZ
Wang Z
CN
Caporaso NE
ML
Morton LM
SR
Severson RK
RE
Riboli E
VP
Vineis P
VR
Vermeulen RC
SM
Southey MC
MR
Milne RL
CJ
Clavel J
TS
Topka S
SJ
Spinelli JJ
KP
Kraft P
EM
Ennas MG
SG
Summerfield G
FG
Ferri GM
HR
Harris RJ
ML
Miligi L
PA
Pettitt AR
NK
North KE
AD
Allsup DJ
FJ
Fraumeni JF
BJ
Bailey JR
OK
Offit K
PG
Pratt G
HH
Hjalgrim H
PC
Pepper C
CS
Chanock SJ
FC
Fegan C
RR
Rosenquist R
DS
de Sanjose S
CA
Carracedo A
DM
Dyer MJ
CD
Catovsky D
CE
Campo E
CJ
Cerhan JR
AJ
Allan JM
RN
Rothman N
HR
Houlston R
SS
Slager S
Chapter II

Abstract

Summary of the research findings

Several chronic lymphocytic leukaemia (CLL) susceptibility loci have been reported; however, much of the heritable risk remains unidentified. Here we perform a meta-analysis of six genome-wide association studies, imputed using a merged reference panel of 1,000 Genomes and UK10K data, totalling 6,200 cases and 17,598 controls after replication. We identify nine risk loci at 1p36.11 (rs34676223, P=5.04 × 10-13), 1q42.13 (rs41271473, P=1.06 × 10-10), 4q24 (rs71597109, P=1.37 × 10-10), 4q35.1 (rs57214277, P=3.69 × 10-8), 6p21.31 (rs3800461, P=1.97 × 10-8), 11q23.2 (rs61904987, P=2.64 × 10-11), 18q21.1 (rs1036935, P=3.27 × 10-8), 19p13.3 (rs7254272, P=4.67 × 10-8) and 22q13.33 (rs140522, P=2.70 × 10-9). These new and established risk loci map to areas of active chromatin and show an over-representation of transcription factor binding for the key determinants of B-cell development and immune response.

4,478 European ancestry cases and 13,213 European ancestry controls.

Chapter III

Study Statistics

Key metrics and study information

23798
Total Participants
GWAS
Study Type
Yes
Replicated
1,722 European ancestry cases and 4,385 European ancestry controls.
Replication Participants
European
Ancestry
U.S., U.K., Australia
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.